Q2 2024 EPS Estimates for AstraZeneca PLC Lowered by Analyst (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN – Free Report) – Stock analysts at Zacks Research dropped their Q2 2024 EPS estimates for AstraZeneca in a note issued to investors on Wednesday, May 15th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.91 for the quarter, down from their previous estimate […]

Related Keywords

,Astrazeneca ,Deutsche Bank Aktiengesellschaft ,Panagora Asset Management Inc ,Hr Department ,Money Concepts Capital Corp ,Morgan Stanley ,Zacks Research ,Allspring Global Investments Holdings ,Sumitomo Mitsui Trust Holdings Inc ,Free Report ,Get Free Report ,Global Investments Holdings ,Mitsui Trust Holdings ,Asset Management ,Concepts Capital Corp ,Astrazeneca Daily ,